Gland Pharma Limited

NSEI:GLAND Rapporto sulle azioni

Cap. di mercato: ₹294.4b

Gland Pharma Crescita futura

Future criteri di controllo 4/6

Gland Pharma prevede che gli utili e i ricavi cresceranno rispettivamente di 25.8% e 11.1% all'anno. Si prevede che l'EPS crescerà di 25.9% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 11% in 3 anni.

Informazioni chiave

25.8%

Tasso di crescita degli utili

25.9%

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili17.7%
Tasso di crescita dei ricavi11.1%
Rendimento futuro del capitale proprio11.0%
Copertura analitica

Good

Ultimo aggiornamento05 Nov 2024

Aggiornamenti recenti sulla crescita futura

Gland Pharma Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Nov 07
Gland Pharma Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Gland Pharma Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 09
Gland Pharma Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

May 25
Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

Recent updates

Gland Pharma Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Nov 07
Gland Pharma Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Gland Pharma Limited (NSE:GLAND) Shares Could Be 23% Above Their Intrinsic Value Estimate

Oct 26
Gland Pharma Limited (NSE:GLAND) Shares Could Be 23% Above Their Intrinsic Value Estimate

Gland Pharma (NSE:GLAND) Has A Pretty Healthy Balance Sheet

Oct 01
Gland Pharma (NSE:GLAND) Has A Pretty Healthy Balance Sheet

Investors Still Waiting For A Pull Back In Gland Pharma Limited (NSE:GLAND)

Sep 05
Investors Still Waiting For A Pull Back In Gland Pharma Limited (NSE:GLAND)

Gland Pharma Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 09
Gland Pharma Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Does Gland Pharma (NSE:GLAND) Have A Healthy Balance Sheet?

Jun 22
Does Gland Pharma (NSE:GLAND) Have A Healthy Balance Sheet?

Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

May 25
Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

Is Gland Pharma (NSE:GLAND) A Risky Investment?

Mar 19
Is Gland Pharma (NSE:GLAND) A Risky Investment?

Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Feb 16
Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

May 20
Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 07
Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Jul 22
Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Jul 14
Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

Feb 08
Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

Previsioni di crescita degli utili e dei ricavi

NSEI:GLAND - Stime future degli analisti e dati finanziari passati (INR Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/202776,95513,1328,38610,3379
3/31/202668,95211,0357,2709,27310
3/31/202561,1548,1645,4296,80710
9/30/202458,9016,9168,19512,187N/A
6/30/202458,5777,221N/AN/AN/A
3/31/202456,6477,7255,9859,968N/A
12/31/202349,1236,587N/AN/AN/A
9/30/202343,0546,9888323,901N/A
6/30/202339,7647,460N/AN/AN/A
3/31/202336,2467,8101,4083,640N/A
12/31/202239,4269,883N/AN/AN/A
9/30/202240,67610,2936,7479,508N/A
6/30/202241,03710,902N/AN/AN/A
3/31/202244,00712,1172,6877,908N/A
12/31/202141,85411,862N/AN/AN/A
9/30/202139,81511,1723284,688N/A
6/30/202137,32610,340N/AN/AN/A
3/31/202134,6299,9703,7626,049N/A
12/31/202032,1049,313N/AN/AN/A
6/30/202028,4309,0277,0259,058N/A
3/31/202026,3327,7295,0637,009N/A
3/31/201920,4424,5194951,853N/A
3/31/201816,1993,211N/A2,021N/A
3/31/201714,7924,137N/A4,765N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di GLAND ( 25.8% all'anno) è superiore al tasso di risparmio ( 6.7% ).

Guadagni vs Mercato: Si prevede che gli utili di GLAND ( 25.8% all'anno) cresceranno più rapidamente del mercato Indian ( 18% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di GLAND cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di GLAND ( 11.1% all'anno) crescerà più rapidamente del mercato Indian ( 10.5% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di GLAND ( 11.1% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di GLAND sarà basso tra 3 anni ( 11 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y